Vident Advisory’s Veracyte VCYT Stock Holding History

Vident Advisory’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$214K	Buy	6,649 +602	+10%	+$22.3K	﹤0.01%	1670
2025 Q4	$255K	Sell	6,047 -310	-5%	-$12.5K	﹤0.01%	1448
2025 Q3	$218K	Buy	+6,357	New	+$182K	﹤0.01%	1534
2025 Q1	–	Sell	-9,199	Closed	-$364K	–	1636
2024 Q4	$364K	Buy	+9,199	New	+$348K	0.01%	1089
2024 Q3	–	Sell	-16,084	Closed	-$349K	–	1560
2024 Q2	$349K	Sell	16,084 -768	-5%	-$16.1K	0.01%	1065
2024 Q1	$373K	Buy	16,852 +1,081	+7%	+$26.4K	0.01%	937
2023 Q4	$434K	Sell	15,771 -8,895	-36%	-$215K	0.01%	839
2023 Q3	$551K	Buy	+24,666	New	+$634K	0.02%	672

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Vident Advisory's VCYT Position: Q1 2026 in Review

Vident Advisory increased its Veracyte (VCYT) stake by 10% in Q1 2026, buying an estimated $22.3K and bringing the position to 6,649 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

Vident Advisory first reported a position in VCYT in Q3 2023 and has held it in 8 quarters since. The position peaked at $551K in Q3 2023. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Vident Advisory held 6,649 shares of Veracyte worth $214K as of Q1 2026.
Vident Advisory bought 602 Veracyte shares in Q1 2026, an estimated $22.3K.
Veracyte made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1670 holding.
Vident Advisory first reported a position in Veracyte in Q3 2023 and has held it in 8 quarters since.
Vident Advisory's Veracyte position peaked at $551K in Q3 2023.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.